For individuals with diabetes, insulin therapy is often necessary to control blood glucose levels. However, there has been concern that exogenous insulin might influence cancer outcomes. Some studies suggest a potential link between insulin therapy and increased cancer risk, while others have found no significant association. The type of insulin and the dosage might also play a role, with some evidence suggesting that long-acting insulins might carry a different risk profile compared to short-acting ones.
